Catalyst Wire Dossier Catalyst Wire Dossier

OC-02 nasal spray

OC-02 · Oyster Point Pharma, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OC-02 nasal spray, covering 2021-12-14 to 2022-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (the RAINIER Study) [Phase 2]

See pricing